Skip to main content
. 2018 Dec 14;19(2):1203–1209. doi: 10.3892/mmr.2018.9765

Figure 2.

Figure 2.

Metformin suppresses the EMT process in HCT116 colorectal cancer cells. (A) mRNA and (B) protein levels of EMT markers (E-cadherin and Vimentin) were detected in HCT116 colorectal cancer cells treated with different concentrations of metformin. (C) mRNA and (D) protein levels of EMT markers (E-cadherin and Vimentin) were detected in HCT116 colorectal cancer sphere cells treated with treatment of different concentrations of metformin. Data are presented as the mean ± standard deviation, *P<0.05 and **P<0.01 vs. control. EMT, epithelial-mesenchymal transition.